File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: The impact of reimbursement on the usage of pacemakers, implantable cardioverter defibrillators and radiofrequency ablation

TitleThe impact of reimbursement on the usage of pacemakers, implantable cardioverter defibrillators and radiofrequency ablation
Authors
Issue Date2006
PublisherSpringer New York LLC. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=1383-875X
Citation
Journal Of Interventional Cardiac Electrophysiology, 2006, v. 17 n. 3, p. 177-181 How to Cite?
AbstractAn international questionnaire survey was carried out in Asia Pacific, Europe, Latin America and North America to assess the impact of reimbursement on the indications, types of device prescription and waiting time for pacemakers, implantable cardioverter defibrillators (ICD) and radiofrequency ablation therapy for cardiac arrhythmias. The indications for cardiac pacing can be restricted to more symptomatic patients when funding is limited, and new therapy such as cardiac resynchronization therapy (CRT) is restricted in many regions. ICD usage may be limited to secondary prevention candidates because of reimbursement, but referral doctor's ambivalence and knowledge are also important issues independent of the types of health care system. Radiofrequency ablation is generally well accepted, but reimbursement is heterogeneous, with non-flouroscopic mapping being reimbursed only in a limited way worldwide. Thus with the exception of a well-developed health care system, reimbursement has a major impact on the delivery of arrhythmia management devices and procedures worldwide. © 2007 Springer Science+Business Media, LLC.
Persistent Identifierhttp://hdl.handle.net/10722/76580
ISSN
2015 Impact Factor: 1.676
2015 SCImago Journal Rankings: 0.930
ISI Accession Number ID
References

 

DC FieldValueLanguage
dc.contributor.authorLau, CPen_HK
dc.contributor.authorTse, HFen_HK
dc.contributor.authorMond, HGen_HK
dc.date.accessioned2010-09-06T07:22:45Z-
dc.date.available2010-09-06T07:22:45Z-
dc.date.issued2006en_HK
dc.identifier.citationJournal Of Interventional Cardiac Electrophysiology, 2006, v. 17 n. 3, p. 177-181en_HK
dc.identifier.issn1383-875Xen_HK
dc.identifier.urihttp://hdl.handle.net/10722/76580-
dc.description.abstractAn international questionnaire survey was carried out in Asia Pacific, Europe, Latin America and North America to assess the impact of reimbursement on the indications, types of device prescription and waiting time for pacemakers, implantable cardioverter defibrillators (ICD) and radiofrequency ablation therapy for cardiac arrhythmias. The indications for cardiac pacing can be restricted to more symptomatic patients when funding is limited, and new therapy such as cardiac resynchronization therapy (CRT) is restricted in many regions. ICD usage may be limited to secondary prevention candidates because of reimbursement, but referral doctor's ambivalence and knowledge are also important issues independent of the types of health care system. Radiofrequency ablation is generally well accepted, but reimbursement is heterogeneous, with non-flouroscopic mapping being reimbursed only in a limited way worldwide. Thus with the exception of a well-developed health care system, reimbursement has a major impact on the delivery of arrhythmia management devices and procedures worldwide. © 2007 Springer Science+Business Media, LLC.en_HK
dc.languageengen_HK
dc.publisherSpringer New York LLC. The Journal's web site is located at http://springerlink.metapress.com/openurl.asp?genre=journal&issn=1383-875Xen_HK
dc.relation.ispartofJournal of Interventional Cardiac Electrophysiologyen_HK
dc.subject.meshArrhythmias, Cardiac - therapyen_HK
dc.subject.meshCardiac Pacing, Artificial - economics - utilizationen_HK
dc.subject.meshCatheter Ablation - economics - utilizationen_HK
dc.subject.meshDeath, Sudden, Cardiac - prevention & controlen_HK
dc.subject.meshDefibrillators, Implantable - economics - utilizationen_HK
dc.subject.meshHumansen_HK
dc.subject.meshQuestionnairesen_HK
dc.subject.meshReimbursement Mechanismsen_HK
dc.titleThe impact of reimbursement on the usage of pacemakers, implantable cardioverter defibrillators and radiofrequency ablationen_HK
dc.typeArticleen_HK
dc.identifier.openurlhttp://library.hku.hk:4550/resserv?sid=HKU:IR&issn=1383-875X&volume=17&issue=3&spage=177&epage=81&date=2007&atitle=The+impact+of+reimbursement+on+the+usage+of+pacemakers,+implantable+cardioverter+defibrillators+and+radiofrequency+ablation.en_HK
dc.identifier.emailTse, HF:hftse@hkucc.hku.hken_HK
dc.identifier.authorityTse, HF=rp00428en_HK
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1007/s10840-006-9076-7en_HK
dc.identifier.pmid17373583-
dc.identifier.scopuseid_2-s2.0-34247272002en_HK
dc.identifier.hkuros126518en_HK
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-34247272002&selection=ref&src=s&origin=recordpageen_HK
dc.identifier.volume17en_HK
dc.identifier.issue3en_HK
dc.identifier.spage177en_HK
dc.identifier.epage181en_HK
dc.identifier.isiWOS:000245834200004-
dc.publisher.placeUnited Statesen_HK
dc.identifier.scopusauthoridLau, CP=7401968501en_HK
dc.identifier.scopusauthoridTse, HF=7006070805en_HK
dc.identifier.scopusauthoridMond, HG=7007045933en_HK
dc.identifier.citeulike1355223-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats